Reference: 1. SIMPONI ARIA® [Prescribing Information]. Horsham, PA: Johnson & Johnson.
Consider
As your
TNFi of Choice
where indicated
RA
ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN COMBINATION WITH METHOTREXATE1
PsA
ACTIVE PSORIATIC ARTHRITIS IN PATIENTS 2 YEARS AND OLDER1
AS
ADULT PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS1
DOSING CALCULATOR FOR ADULT PATIENTS
Calculate an adult patient's dose of SIMPONI ARIA® based on weight
EFFICIENT INFUSION1*
A 30-minute infusion given once every 8 weeks—as few as 6 times a year—after starter doses*
*“Efficient” is defined as the total amount of time required to administer SIMPONI ARIA®. For adult patients with RA, PsA, or AS, 2 mg/kg is administered as an intravenous infusion over 30 minutes once every 8 weeks, after starter doses at Weeks 0 and 4. For adult patients with moderately to severely active RA, SIMPONI ARIA® is given in combination with methotrexate. For pediatric patients with pJIA or PsA, 80 mg/m2 of SIMPONI ARIA® is administered as an intravenous infusion over 30 minutes at Weeks 0 and 4, and every 8 weeks thereafter.
AS=ankylosing spondylitis; pJIA=polyarticular juvenile idiopathic arthritis; PsA=psoriatic arthritis; RA=rheumatoid arthritis; TNFi=tumor necrosis factor inhibitor.